表紙
市場調查報告書
商品編碼
1036286

全球自動注射器市場

Autoinjectors: Global Markets

出版日期: | 出版商: BCC Research | 英文 123 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2021年全球自動注射器市場規模達到415億美元。

預計從 2021 年到 2026 年,該市場將以 15.5% 的複合年增長率增長,到 2026 年將達到 852 億美元。

本報告探討了自動注射器的全球市場,概述了市場、產品類型、給藥途徑、治療方法、最終用戶、區域趨勢以及進入市場的公司概況。

目錄

第 1 章介紹

  • 調查目的和目的
  • 進行本次調查的原因
  • 報告範圍
  • 信息來源
  • 調查方法
  • 地域細分
  • 分析師生涯
  • BCC 自定義調查
  • 相關 BCC 調查報告

第 2 章總結和亮點

第三章市場和技術背景

  • 簡介
  • 市場演變

第 4 章 COVID-19 大流行影響

  • COVID-19 對市場的影響
  • 健康相關產品消費趨勢變化

第 5 章市場動態

  • 概述
  • 過敏反應的發生率增加
  • 提高靶向治療的滲透率
  • 市場限制
  • 存在替代給藥途徑
  • 嚴格的監管場景

第 6 章市場細分,按產品類型

  • 自動注射器市場,按產品類型
  • 一次性自動注射器
  • 市場規模和預測
  • 可重複使用的自動注射器
  • 市場規模和預測

第 7 章市場細分,按管理途徑

  • 自動注射器市場,按給藥途徑
  • 肌內註射
  • 市場規模和預測
  • 皮下
  • 市場規模和預測

第 8 章市場細分,按處理

  • 過敏反應
  • 市場規模和預測
  • 類風濕性關節炎
  • 市場規模和預測
  • 多發性硬化症
  • 市場規模和預測
  • 糖尿病
  • 市場規模和預測
  • 其他
  • 市場規模和預測

第 9 章市場細分,按最終用戶

  • 家庭護理設備
  • 市場規模和預測
  • 醫院/診所
  • 市場規模和預測
  • 門診護理設施
  • 市場規模和預測

第 10 章市場細分,按地區

  • 北美
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他
  • 拉丁美洲
  • 中東和非洲

第 11 章監管情景

  • 醫療器械的定義和分類
  • 美國法規
  • 聯邦法規
  • 聯邦法規
  • 營銷前通知 510 (k) 清關
  • 510 (k) 豁免裝置
  • 上市前審批
  • 歐洲法規
  • 北美國家的規定
  • 美國法規
  • 加拿大法規
  • 拉丁美洲法規
  • 亞太地區法規
  • 未來的監管趨勢

第12章競爭形勢

  • 概述
  • 公司排名

第 13 章公司簡介

  • ABBVIE INC.
  • AMGEN INC.
  • ANTARES PHARMA INC.
  • BECTON, DICKINSON AND CO.
  • ELI LILLY AND CO.
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK KGAA
  • SHL MEDICAL AG
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • YPSOMED
目錄
Product Code: MDS058A

Highlights:

The global market for autoinjectors should grow from $41.5 billion in 2021 to $85.2 billion by 2026, at compound annual growth rate (CAGR) of 15.5% for the period of 2021-2026.

The North American market for autoinjectors should grow from $15.1 billion in 2021 to $28.4 billion by 2026, at a CAGR of 13.4% for the period of 2021-2026.

Asia-Pacific market for autoinjectors should grow from $10.2 billion in 2021 to $22.6 billion by 2026, at a CAGR of 17.2% for the period of 2021-2026.

Report Scope:

This report examines the current market and projected market potential for autoinjectors. It offers a detailed analysis of the competitive environment, market background, technology, drivers and restraints, and market growth trends. The report also includes market projections to 2026 and rankings for key market players. The report segments the market for autoinjectors based on the type of product, route of administration, therapy, end user and geography or region.

The market by type of product is further segmented into disposable and reusable autoinjectors. The market by route of administration is further segmented into intramuscular and subcutaneous. The market by therapy is further segmented into anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes, and others. The market by end user is further segmented into home care settings, hospitals and clinics, and ambulatory care settings.

The market by region is segmented into North America, Europe, the Asia-Pacific region, and the Rest of the World. Analyses of major countries are covered in the report. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Estimated values used are based on autoinjector manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 41 data tables and 25 additional tables
  • Detailed review of the global market for autoinjectors within the medical devices industry
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation and forecast the overall autoinjectors market size in dollar value term, and corresponding market share analysis by product type, route of administration, therapy, end user, and region
  • Discussion of key market dynamics (DROs), technology advancements, regulatory scenario, pricing analysis, and competitive environment of the vendor companies
  • Country specific data and market value analysis for the U.S., Canada, U.K., France, Germany, Italy, Spain, Japan, China and India
  • Insight into the recent industry strategies, key M&A deals, company competitive landscape and value share analysis of the key players operating in global autoinjectors market
  • Highlights of the market potential for autoinjectors, opportunities and gaps estimating current and future demand, and impact of COVID-19 on the progress of this market
  • Discussion of competitive intensity among the leading market participants, their global rankings and recent developments in the autoinjector market
  • Company profile descriptions of the leading manufacturers and suppliers of autoinjector devices including AbbVie Inc., Amgen Inc., Becton, Dickinson and Co., Eli Lilly, GlaxoSmithKline PLC, Johnson & Johnson, Merck KGaA, and Teva Pharmaceutical

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Introduction
  • Market Evolution

Chapter 4 Impact of COVID-19 Pandemic

  • Impact of COVID-19 on Markets
  • Changes in Consumption Trends for Health-Related Products

Chapter 5 Market Dynamics

  • Overview
  • Rising Incidence of Anaphylaxis
  • Growing Prevalence of Targeted Therapies
  • Market Restraints
  • Presence of Alternate Drug Delivery Routes
  • Stringent Regulatory Scenario

Chapter 6 Market Breakdown by Product Type

  • Market for Autoinjectors by Product Type
  • Disposable Autoinjectors
  • Market Size and Forecast
  • Reusable Autoinjectors
  • Market Size and Forecast

Chapter 7 Market Breakdown by Route of Administration

  • Market for Autoinjectors by Route of Administration
  • Intramuscular
  • Market Size and Forecast
  • Subcutaneous
  • Market Size and Forecast

Chapter 8 Market Breakdown by Therapy

  • Anaphylaxis
  • Market Size and Forecast
  • Rheumatoid Arthritis
  • Market Size and Forecast
  • Multiple Sclerosis
  • Market Size and Forecast
  • Diabetes
  • Market Size and Forecast
  • Others
  • Market Size and Forecast

Chapter 9 Market Breakdown by End User

  • Home Care Settings
  • Market Size and Forecast
  • Hospitals and Clinics
  • Market Size and Forecast
  • Ambulatory Care Settings
  • Market Size and Forecast

Chapter 10 Market Breakdown by Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Chapter 11 Regulatory Scenarios

  • Medical Device Definition and Classification
  • Regulations in the U.S.
  • Code of Federal Regulations
  • Electronic Code of Federal Regulations
  • Premarket Notification 510(k) Clearance to Market
  • 510(k) Exempt Devices
  • Pre-Market Approval
  • European Regulations
  • Regulation in North American Countries
  • U.S. Regulations
  • Canadian Regulations
  • Regulation in Latin America
  • Regulation in Asia-Pacific
  • Future Regulatory Trends

Chapter 12 Competitive Landscape

  • Overview
  • Company Rankings

Chapter 13 Company Profiles

  • ABBVIE INC.
  • AMGEN INC.
  • ANTARES PHARMA INC.
  • BECTON, DICKINSON AND CO.
  • ELI LILLY AND CO.
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK KGAA
  • SHL MEDICAL AG
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • YPSOMED

List of Tables

  • Summary Table : Global Market for Autoinjectors, by Region, Through 2026
  • Table 1 : Global Market for Autoinjectors, by Product Type, Through 2026
  • Table 2 : Global Market for Disposable Autoinjectors, by Region, Through 2026
  • Table 3 : Global Market for Reusable Autoinjectors, by Region, Through 2026
  • Table 4 : Global Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 5 : Global Market for Intramuscular Autoinjectors, by Region, Through 2026
  • Table 6 : Global Market for Subcutaneous Autoinjectors, by Region, Through 2026
  • Table 7 : Global Market for Autoinjectors, by Therapy, Through 2026
  • Table 8 : Global Market for Autoinjectors for Anaphylaxis Therapy, by Region, Through 2026
  • Table 9 : Global Market for Autoinjectors for Rheumatoid Arthritis Therapy, by Region, Through 2026
  • Table 10 : Global Market for Autoinjectors for Multiple Sclerosis Therapy, by Region, Through 2026
  • Table 11 : Global Market for Autoinjectors for Diabetes Therapy, by Region, Through 2026
  • Table 12 : Global Market for Autoinjectors for Other Therapies, by Region, Through 2026
  • Table 13 : Global Market for Autoinjectors, by End User Setting, Through 2026
  • Table 14 : Global Market for Autoinjectors Used in Home Care Settings, by Region, Through 2026
  • Table 15 : Global Market for Autoinjectors Used in Hospitals and Clinics, by Region, Through 2026
  • Table 16 : Global Market for Injectors Used in Ambulatory Care Settings, by Region, Through 2026
  • Table 17 : Global Market for Autoinjectors, by Region, Through 2026
  • Table 18 : North American Market for Autoinjectors, by Product Type, Through 2026
  • Table 19 : North American Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 20 : North American Market for Autoinjectors, by Therapy, Through 2026
  • Table 21 : North American Market for Autoinjectors, by End User Setting, Through 2026
  • Table 22 : North American Market for Autoinjectors, by Country, Through 2026
  • Table 23 : European Market for Autoinjectors, by Product Type, Through 2026
  • Table 24 : European Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 25 : European Market for Autoinjectors, by Therapy, Through 2026
  • Table 26 : European Market for Autoinjectors, by End User Setting, Through 2026
  • Table 27 : European Market for Autoinjectors, by Country, Through 2026
  • Table 28 : Asia-Pacific Market for Autoinjectors, by Product Type, Through 2026
  • Table 29 : Asia-Pacific Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 30 : Asia-Pacific Market for Autoinjectors, by Therapy, Through 2026
  • Table 31 : Asia-Pacific Market for Autoinjectors, by End User Setting, Through 2026
  • Table 32 : Asia-Pacific Market for Autoinjectors, by Country, Through 2026
  • Table 33 : Latin American Market for Autoinjectors, by Product Type, Through 2026
  • Table 34 : Latin American Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 35 : Latin American Market for Autoinjectors, by Therapy, Through 2026
  • Table 36 : Latin American Market for Autoinjectors, by End User Setting, Through 2026
  • Table 37 : Middle Eastern and African Market for Autoinjectors, by Product Type, Through 2026
  • Table 38 : Middle Eastern and African Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 39 : Middle Eastern and African Market for Autoinjectors, by Therapy, Through 2026
  • Table 40 : Middle Eastern and African Market for Autoinjectors, by End User Setting, Through 2026
  • Table 41 : Class I and Class II Exempt Devices
  • Table 42 : Differences Between U.S. and European Government Regulations for Medical Devices
  • Table 43 : Regulation in Selected Asia-Pacific Countries
  • Table 44 : Top Five Companies in the Autoinjector Market, 2020
  • Table 45 : Recent Developments in the Autoinjector Market, 2018 to 2021
  • Table 46 : AbbVie: Product Portfolio
  • Table 47 : Amgen: Product Portfolio
  • Table 48 : Amgen: Recent Developments, 2021
  • Table 49 : Antares Pharma: Product Portfolio
  • Table 50 : Antares Pharma: Recent Developments
  • Table 51 : BD: Product Portfolio
  • Table 52 : BD: Recent Developments
  • Table 53 : Eli Lilly: Product Portfolio
  • Table 54 : Eli Lilly: Recent Developments
  • Table 55 : GlaxoSmithKline PLC: Products
  • Table 56 : GlaxoSmithKline PLC: Recent Developments
  • Table 57 : Johnson & Johnson: Product Portfolio
  • Table 58 : Johnson & Johnson: Recent Developments
  • Table 59 : Merck KGaA: Product Portfolio
  • Table 60 : SHL Medical AG: Product Portfolio
  • Table 61 : SHL Medical Ag: Recent Developments
  • Table 62 : Teva Pharmaceutical: Product Portfolio
  • Table 63 : Teva Pharmaceutical: Recent Developments
  • Table 64 : Ypsomed: Product Portfolio
  • Table 65 : Ypsomed: Recent Developments

List of Figures

  • Summary Figure A : Global Market for Autoinjectors, by Region, 2019-2026
  • Summary Figure B : Global Market Shares for Autoinjectors, by Region, 2020
  • Figure 1 : Global Market Share for Autoinjectors, by Product Type, 2020
  • Figure 2 : Global Market for Autoinjectors, by Product Type, 2019-2026
  • Figure 3 : Global Market for Disposable Autoinjectors, 2019-2026
  • Figure 4 : Global Market for Reusable Autoinjectors, 2019-2026
  • Figure 5 : Global Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 6 : Global Market for Autoinjectors, by Route of Administration, 2019-2026
  • Figure 7 : Global Market for Intramuscular Autoinjectors, 2019-2026
  • Figure 8 : Global Market for Subcutaneous Autoinjectors, 2019-2026
  • Figure 9 : Global Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 10 : Global Market for Autoinjectors, by Therapy, 2019-2026
  • Figure 11 : Global Market for Autoinjectors for Anaphylaxis Therapy, 2019-2026
  • Figure 12 : Global Market for Autoinjectors for Rheumatoid Arthritis Therapy, 2019-2026
  • Figure 13 : Global Market for Autoinjectors for Multiple Sclerosis Therapy, 2019-2026
  • Figure 14 : Global Market for Autoinjectors for Diabetes Therapy, 2019-2026
  • Figure 15 : Global Market for Autoinjectors for Other Therapies, 2019-2026
  • Figure 16 : Global Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 17 : Global Market for Autoinjectors Used in Home Care Settings, 2019-2026
  • Figure 18 : Global Market for Autoinjectors Used in Home Care Settings, by Region, 2019-2026
  • Figure 19 : Global Market for Autoinjectors Used in Hospitals and Clinics, 2019-2026
  • Figure 20 : Global Market for Autoinjectors Used in Hospitals and Clinics, by Region, 2019-2026
  • Figure 21 : Global Market for Autoinjectors Used in Ambulatory Care Settings, 2019-2026
  • Figure 22 : Global Market for Autoinjectors Used in Ambulatory Care Settings, by Region, 2019-2026
  • Figure 23 : Global Market Shares of Autoinjectors, by Region, 2020
  • Figure 24 : North American Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 25 : North American Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 26 : North American Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 27 : North American Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 28 : North American Market Shares of Autoinjectors, by Country, 2020
  • Figure 29 : U.S. Market for Autoinjectors, 2019-2026
  • Figure 30 : Canadian Market for Autoinjectors, 2019-2026
  • Figure 31 : European Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 32 : European Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 33 : European Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 34 : European Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 35 : European Market Shares of Autoinjectors, by Country, 2020
  • Figure 36 : German Market for Autoinjectors, 2019-2026
  • Figure 37 : U.K. Market for Autoinjectors, 2019-2026
  • Figure 38 : French Market for Autoinjectors, 2019-2026
  • Figure 39 : Italian Market for Autoinjectors, 2019-2026
  • Figure 40 : Spanish Market for Autoinjectors, 2019-2026
  • Figure 41 : Rest of European Market for Autoinjectors, 2019-2026
  • Figure 42 : Asia-Pacific Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 43 : Asia-Pacific Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 44 : Asia-Pacific Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 45 : Asia-Pacific Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 46 : Asia-Pacific Market Shares of Autoinjectors, by Country, 2020
  • Figure 47 : Chinese Market for Autoinjectors, 2019-2026
  • Figure 48 : Japanese Market for Autoinjectors, 2019-2026
  • Figure 49 : India's Market for Autoinjectors, 2019-2026
  • Figure 50 : Rest of Asia-Pacific Market for Autoinjectors, 2019-2026
  • Figure 51 : Latin American Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 52 : Latin American Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 53 : Latin American Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 54 : Latin American Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 55 : Middle Eastern and African Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 56 : Middle Eastern and African Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 57 : Middle Eastern and African Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 58 : Middle Eastern and African Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 59 : Marketing a Medical Device in the U.S.
  • Figure 60 : AbbVie: Annual Revenue, 2016-2020
  • Figure 61 : AbbVie: Revenue Share, by Region, 2020
  • Figure 62 : AbbVie: Revenue Share, by Business Unit, 2020
  • Figure 63 : Amgen: Annual Revenue, 2018-2020
  • Figure 64 : Amgen: Revenue Share, by Region, 2020
  • Figure 65 : Antares Pharma: Annual Revenue, 2018-2020
  • Figure 66 : Antares Pharma: Revenue Share, by Region, 2020
  • Figure 67 : BD: Annual Revenue, 2018-2020
  • Figure 68 : BD: Revenue Share, by Region, 2020
  • Figure 69 : BD: Revenue Share, by Business Segment, 2020
  • Figure 70 : Eli Lilly: Annual Revenue, 2017-2020
  • Figure 71 : Eli Lilly: Revenue Share, by Region, 2020
  • Figure 72 : Eli Lilly: Revenue Share, by Segment, 2020
  • Figure 73 : GlaxoSmithKline PLC: Annual Revenue, 2017-2020
  • Figure 74 : GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2020
  • Figure 75 : GlaxoSmithKline PLC: Revenue Share, by Region, 2020
  • Figure 76 : Johnson & Johnson: Annual Revenue, 2016-2019
  • Figure 77 : Johnson & Johnson: Revenue Share, by Region, 2019
  • Figure 78 : Johnson & Johnson: Revenue Share, by Business Unit, 2019
  • Figure 79 : Merck KGaA: Annual Revenue, 2019-2020
  • Figure 80 : Merck KGaA: Revenue Share, by Region, 2020
  • Figure 81 : Merck KGaA: Revenue Share, by Business Segment, 2020
  • Figure 82 : Teva Pharmaceutical: Annual Revenue, 2017-2020
  • Figure 83 : Ypsomed: Annual Revenue, 2018-2020